According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), intervention meetings are different to more traditional alcoholism treatment programs. While this type of meeting is usually designed for a person who is on the cusp of developing an alcohol problem, they can also help motivate an alcoholic in to seeking more extensive treatment for their alcoholism. The best intervention meetings are usually those that both the alcoholic person and family can attend together. This allows the family to discuss how the individual's alcoholism has affected them as a unit. This is also a good setting for loved ones to strongly demand that the individual seek treatment, as they have the backup of professional counselors.
Drug detox: Detox, short for detoxification, is the first phase in many substance abuse treatment programs. During detox, patients are monitored by professionals during their withdrawal from drugs. Medications, nutritional supplementation and fluid replacement may be provided to relieve withdrawal symptoms. At the same time, counseling is provided to encourage the patient to move forward to the next phase of rehabilitation.
Treatments and attitudes toward addiction vary widely among different countries. In the US and developing countries, the goal of commissioners of treatment for drug dependence is generally total abstinence from all drugs. Other countries, particularly in Europe, argue the aims of treatment for drug dependence are more complex, with treatment aims including reduction in use to the point that drug use no longer interferes with normal activities such as work and family commitments; shifting the addict away from more dangerous routes of drug administration such as injecting to safer routes such as oral administration; reduction in crime committed by drug addicts; and treatment of other comorbid conditions such as AIDS, hepatitis and mental health disorders. These kinds of outcomes can be achieved without eliminating drug use completely. Drug treatment programs in Europe often report more favorable outcomes than those in the US because the criteria for measuring success are functional rather than abstinence-based. The supporters of programs with total abstinence from drugs as a goal believe that enabling further drug use means prolonged drug use and risks an increase in addiction and complications from addiction. Jordan Peterson - How to treat addiction effectively
Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Doctor On Demand
Received income in an amount equal to or greater than $250 from: Blue Cross Blue Shield Federal Employee Program
Received royalty from Lippincott Williams & Wilkins for book editor; Received grant/research funds from National Alliance for Research in Schizophrenia and Depression for independent contractor; Received consulting fee from Blue Cross Blue Shield Association for consulting. for: Received book royalty from American Psychiatric Publishing Inc.
^ Blum K, Werner T, Carnes S, Carnes P, Bowirrat A, Giordano J, Oscar-Berman M, Gold M (2012). "Sex, drugs, and rock 'n' roll: hypothesizing common mesolimbic activation as a function of reward gene polymorphisms". Journal of Psychoactive Drugs. 44 (1): 38–55. doi:10.1080/02791072.2012.662112. PMC 4040958. PMID 22641964. It has been found that deltaFosB gene in the NAc is critical for reinforcing effects of sexual reward. Pitchers and colleagues (2010) reported that sexual experience was shown to cause DeltaFosB accumulation in several limbic brain regions including the NAc, medial pre-frontal cortex, VTA, caudate, and putamen, but not the medial preoptic nucleus. Next, the induction of c-Fos, a downstream (repressed) target of DeltaFosB, was measured in sexually experienced and naive animals. The number of mating-induced c-Fos-IR cells was significantly decreased in sexually experienced animals compared to sexually naive controls. Finally, DeltaFosB levels and its activity in the NAc were manipulated using viral-mediated gene transfer to study its potential role in mediating sexual experience and experience-induced facilitation of sexual performance. Animals with DeltaFosB overexpression displayed enhanced facilitation of sexual performance with sexual experience relative to controls. In contrast, the expression of DeltaJunD, a dominant-negative binding partner of DeltaFosB, attenuated sexual experience-induced facilitation of sexual performance, and stunted long-term maintenance of facilitation compared to DeltaFosB overexpressing group. Together, these findings support a critical role for DeltaFosB expression in the NAc in the reinforcing effects of sexual behavior and sexual experience-induced facilitation of sexual performance. ... both drug addiction and sexual addiction represent pathological forms of neuroplasticity along with the emergence of aberrant behaviors involving a cascade of neurochemical changes mainly in the brain's rewarding circuitry. How to stop drinking alcohol - how to help an alcoholic
The action stage of change represents full recognition of a problem along with observable evidence of steps taken to reduce alcohol use. The clinician should reinforce and praise the decision to change. Emphasizing that the biggest error at this stage is to underestimate the amount of help needed to quit drinking is critical. The patient should be given a list of options for treatment including AA and pharmacotherapy. Eminem on drugs, addiction and rehab
When you have a child struggling with substance abuse, attempting to handle it on your own can be extremely overwhelming and can eventually become your first and only priority. It may also be difficult to take the first step because addressing the problem is disruptive of school and extracurricular activities.2 However, addiction is far more disruptive to your child's life in the end, and treatment can work. Taking the time now to get help can save your child's life.
When you stop using alcohol altogether, you may experience withdrawal symptoms. The detoxification stage is the first step in the recovery process. It involves eliminating alcohol from your body completely. The most severe withdrawal symptoms generally surface within the first 24 to 48 hours after your last drink. While some symptoms are minor, others can be more serious. Your treatment specialist will be able to give you medications in order to help alleviate some of the pain.
Inpatient treatment programs require the patient to live at the facility for the duration—typically 30, 60, or 90 days—of treatment. The process often starts with detoxification. During this time, withdrawal symptoms are managed in a safe environment by qualified medical staff. Medications may be administered to alleviate or prevent serious symptoms.
Nalmefene, an opiate antagonist that is similar in its chemical structure to naltrexone, is one of the most recent drugs being investigated for the treatment of alcoholism. Like naltrexone (sold as ReVia, Depade, or Vivitrol), nalmefene deprives the person struggling with substance use of the pleasurable feelings associated with drinking. But nalmefene is less toxic to the liver than naltrexone. As of 2013, nalmefene was still undergoing clinical trials through the U.S. National Institutes of Health before receiving FDA approval.